title: Multifunctional double-negative T cells in sooty mangabeys mediate T-helper functions irrespective of SIV infection.
abstract: Studying SIV infection of natural host monkey species, such as sooty mangabeys, has provided insights into the immune changes associated with these nonprogressive infections. Mangabeys maintain immune health despite high viremia or the dramatic CD4 T cell depletion that can occur following multitropic SIV infection. Here we evaluate double-negative (DN)(CD3+CD4-CD8-) T cells that are resistant to SIV infection due to a lack of CD4 surface expression, for their potential to fulfill a role as helper T cells. We first determined that DN T cells are polyclonal and predominantly exhibit an effector memory phenotype (CD95+CD62L-). Microarray analysis of TCR (anti-CD3/CD28) stimulated DN T cells indicated that these cells are multifunctional and upregulate genes with marked similarity to CD4 T cells, such as immune genes associated with Th1 (IFNγ), Th2 (IL4, IL5, IL13, CD40L), Th17 (IL17, IL22) and TFH (IL21, ICOS, IL6) function, chemokines such as CXCL9 and CXCL10 and transcription factors known to be actively regulated in CD4 T cells. Multifunctional T-helper cell responses were maintained in DN T cells from uninfected and SIV infected mangabeys and persisted in mangabeys exhibiting SIV mediated CD4 loss. Interestingly, TCR stimulation of DN T cells from SIV infected mangabeys results in a decreased upregulation of IFNγ and increased IL5 and IL13 expression compared to uninfected mangabeys. Evaluation of proliferative capacity of DN T cells in vivo (BrDU labeling) indicated that these cells maintain their ability to proliferate despite SIV infection, and express the homeostatic cytokine receptors CD25 (IL2 receptor) and CD127 (IL7 receptor). This study identifies the potential for a CD4-negative T cell subset that is refractory to SIV infection to perform T-helper functions in mangabeys and suggests that immune therapeutics designed to increase DN T cell function during HIV infection may have beneficial effects for the host immune system.
authors.affiliation: Seattle Biomedical Research Institute, Seattle, Washington, United States of America.
authors.forename: Vasudha
authors.initials: V
authors.lastname: Sundaravaradan
authors.forename: Ramsey
authors.initials: R
authors.lastname: Saleem
authors.forename: Luca
authors.initials: L
authors.lastname: Micci
authors.forename: Melanie A
authors.initials: MA
authors.lastname: Gasper
authors.forename: Alexandra M
authors.initials: AM
authors.lastname: Ortiz
authors.forename: James
authors.initials: J
authors.lastname: Else
authors.forename: Guido
authors.initials: G
authors.lastname: Silvestri
authors.forename: Mirko
authors.initials: M
authors.lastname: Paiardini
authors.forename: John D
authors.initials: JD
authors.lastname: Aitchison
authors.forename: Donald L
authors.initials: DL
authors.lastname: Sodora
mesh_terms: D000818:Animals; D016665:Cercocebus atys; D016207:Cytokines / Q000097:blood / Q000235:genetics / Q000276:immunology*; D011948:Receptors, Antigen, T-Cell / Q000097:blood / Q000235:genetics / Q000276:immunology*; D016097:Simian Acquired Immunodeficiency Syndrome / Q000097:blood / Q000235:genetics / Q000276:immunology*; D015302:Simian Immunodeficiency Virus / Q000235:genetics / Q000276:immunology* / Q000378:metabolism; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism
chemical_list: D016207:Cytokines; D011948:Receptors, Antigen, T-Cell